Mobile: +91 992-500-9739

Tele: +91 79 403-07106

Email: info@newedgeoverseas.com

Alfacalcidol

Alfacalcidol supplier & exporter

Product Description

API name Alfacalcidol
CAS Number 41294-56-8
Therapeutic Category Vitamin D Supplement, Calcium Regulator
Route of Administration Capsule, oral drops, Injection
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Alfacalcidol

Mechanism of Action:

In conditions like chronic renal failure, renal bone disease, hypoparathyroidism, and vitamin D dependent rickets, the kidneys’ capacity for 1α-hydroxylation is impaired, leading to reduced production of endogenous 1,25-dihydroxyvitamin D and aberrated mineral metabolism. As an active and potent analog of vitamin D, alfacalcidol works to restore the functions and activities of endogenous 1,25-dihydroxyvitamin D

 

Drug Indications:

Alfacalcidol is indicated in the management of nutritional and malabsorptive rickets and osteomalacia, vitamin D-dependent rickets and osteomalacia, and hypophosphataemic vitamin D resistant rickets and osteomalacia.

Alendronate Sodium

Alendronate Sodium supplier & exporter

Product Description

API name Alendronate Sodium
CAS Number 121268-17-5
Therapeutic Category Antiosteoporotic
Route of Administration Tablet
Regulatory Documents USDMF, CEP, ASMF, CANADA DMF, TAIWAN DMF, DMF, JDMF, CEP, WC

 

Trader & Wholesaler of Alendronate Sodium

Mechanism of Action:


Alendronic acid binds to bone hydroxyapatite. Bone resorption causes local acidification, releasing alendronic acid which is that taken into osteoclasts by fluid-phase endocytosis. Endocytic vesicles are acidified, releasing alendronic acid to the cytosol of osteoclasts where they induce apoptosis.

Drug Indications:

Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget’s disease of bone.

Alectinib HCl

Alectinib HCl supplier & exporter

Product Description

API name Alectinib HCl
CAS Number 1256589-74-8
Therapeutic Category Anticancer, Antineoplastic
Route of Administration Capsule
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Alectinib HCl

Mechanism of Action:

Alectinib hydrochloride is an ALK kinase inhibitor, which inhibits ALK phosphorylation and ALK-media- ted activation of the downstream signaling proteins STAT3 and AKT, and decreases tumor cell viability in multiple cell lines harboring ALK fusions,

Drug Indications:

Alectinib HCl as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

Alectinib

Alectinib supplier & exporter

Product Description

API name Alectinib
CAS Number 1256580-46-7
Therapeutic Category Anticancer, Antineoplastic
Route of Administration Capsule
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Alectinib

Mechanism of Action:

Alectinib is a second generation oral drug that selectively inhibits the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase. It is specifically used in the treatment of non-small cell lung cancer (NSCLC) expressing the ALK-EML4 (echinoderm microtubule-associated protein-like 4) fusion protein that causes proliferation of NSCLC cells.

Drug Indications:

Alectinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib

Alcaftadine

Alcaftadine supplier & exporter

Product Description

API name Alcaftadine
CAS Number 147084-10-4
Therapeutic Category Antihistamine
Route of Administration Drops, Liquid, Solution, ophthalmic
Regulatory Documents USDMF, DMF

Trader & Wholesaler of Alcaftadine

Mechanism of Action:

Alcaftadine is a H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.

Drug Indications:

For the prevention of itching associated with allergic conjunctivitis.

Albendazole

Albendazole supplier & exporter

Product Description

API name Albendazole
CAS Number 54965-21-8
Therapeutic Category Anthelmintic
Route of Administration Tablet, Suspension, coated
Regulatory Documents TECH PACK, DMF, USDMF

Trader & Wholesaler of Albendazol

Mechanism of Action:

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by diminishing its energy production, ultimately leading to immobilization and death of the parasite. It works by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.Albendazole also prevents the formation of spindle fibers needed for cell division, which in turn blocks egg production and development; existing eggs are prevented from hatching

Drug Indications:

ALBENZA is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Agomelatine (Form I & II)

Agomelatine (Form I & II) supplier & exporter

Product Description

API name Agomelatine (Form I & II)
CAS Number 138112-76-2
Therapeutic Category Antidepressant
Route of Administration Tablet
Regulatory Documents TECH PACK, DMF, WC, USDMF, ASMF, CEP, MEXICO DMF, BRAZIL DMF, TAIWAN DMF, KDMF, JDMF

Trader & Wholesaler of Agomelatine (Form I & II)

Mechanism of Action:

The novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors (MT1 and MT2) and as an antagonist at serotonin (5-HT)(2C) receptors.

Drug Indications:

Agomelatine is indicated to treat major depressive episodes in adults. Build, train, & validate predictive machine-learning models with structured datasets. Avoid life-threatening adverse drug events & improve clinical decision support

Afatinib

Afatinib supplier & exporter

Product Description

API name Afatinib
CAS Number 850140-72-6
Therapeutic Category Anticancer, Antineoplastic
Route of Administration Tablet
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Afatinib

Mechanism of Action:

Afatinib is a potent and selective, irreversible ErbB family blocker 3. Afatinib covalently binds to and irreversibly blocks signaling from all homo and heterodimers formed by the ErbB familyn particular, afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling Label. Certain mutations in EGFR, including non-resistant mutations in its kinase domain, can result in increased autophosphorylation of the receptor, leading to receptor activation, sometimes in the absence of ligand binding, and can support cell proliferation in NSCL

Drug Indications:

Afatinib is a kinase inhibitor indicated as monotherapy 3 for the first-line Label treatment of (a) Epidermal Growth Factor Receptor (EGFR) TKI (tyrosine kinase inhibitor)-naive adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have non-resistant EGFR mutations as detected by an FDA-approved test Label, and (b) adult patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.

Adriamycin, Doxorubicin

Adriamycin, Doxorubicin supplier & exporter

Product Description

API name Adriamycin, Doxorubicin
CAS Number 23214-92-8
Therapeutic Category Anticancer, Antineoplastic
Route of Administration Injection, Powder, solution
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Adriamycin, Doxorubicin

Mechanism of Action:

Doxorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.

Drug Indications:

Doxorubicin is used to produce regression in disseminated neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms’ tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, Hodgkin’s disease, malignant lymphoma and bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types. Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer.

Adrenocorticotropic Hormone

Adrenocorticotropic Hormone supplier & exporter

Product Description

API name Adrenocorticotropic Hormone
CAS Number 9002-60-2
Therapeutic Category Hormone
Route of Administration Powder, Injection
Regulatory Documents TECH PACK, DMF

Trader & Wholesaler of Adrenocorticotropic Hormone

Mechanism of Action:

As a diagnostic aid (adrenocortical function), corticotropin combines with a specific receptor on the adrenal cell plasma membrane. In patients with normal adrenocortical function, it stimulates the initial reaction involved in the synthesis of adrenal steroids from cholesterol by increasing the quantity of cholesterol within the mitochondria.

Drug Indications:

For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.

Purified corticotropin for injection is indicated for a variety of allergic and autoimmune conditions.